Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Oncology Institute (TOI) Other Gross PP&E Adjustments (2020 - 2025)

Oncology Institute's Other Gross PP&E Adjustments history spans 6 years, with the latest figure at -$10.5 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 61.18% year-over-year to -$10.5 million; the TTM value through Dec 2025 reached -$10.5 million, up 61.18%, while the annual FY2025 figure was -$10.5 million, 61.18% up from the prior year.
  • Other Gross PP&E Adjustments reached -$10.5 million in Q4 2025 per TOI's latest filing, up from -$23.8 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$127000.0 in Q4 2021 to a low of -$32.3 million in Q4 2023.
  • Average Other Gross PP&E Adjustments over 5 years is -$21.6 million, with a median of -$23.8 million recorded in 2025.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 16700.0% in 2022, then surged 61.18% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$127000.0 in 2021, then tumbled by 16700.0% to -$21.3 million in 2022, then crashed by 51.56% to -$32.3 million in 2023, then rose by 16.73% to -$26.9 million in 2024, then soared by 61.18% to -$10.5 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Other Gross PP&E Adjustments are -$10.5 million (Q4 2025), -$23.8 million (Q3 2025), and -$23.8 million (Q2 2025).